Amino acids in wound healing

Efficacy of Astymin 3 as an add on therapy to standard of care in reduction of hospitalization and improving wound healing in postoperative patients A Randomized single blind controlled clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042356

Enrollment

200

Registered

2022-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Astymin 3 20ml: Astymin 3 20ml for a period of 1 week along with the standard treatment Control Intervention1: standard of care: standard of care for 7 days

Eligibility

Inclusion criteria

Inclusion criteria: Patients elected for open abdominal surgeries such as inguinal hernia surgery Cholecystectomy Appendectomy

Exclusion criteria

Exclusion criteria: Laparoscopic surgeries Patients with type 1 or type 2 diabetes m Chronic renal failure Acute kidney injury Chronic alcoholic patients Smokers Obesity BMI more than 25 Any major surgical procedure involving excessive blood loss more than 1 liter COPD CHF and anemia

Design outcomes

Primary

Measure	Time frame
changes in days of hospitalizationTimepoint: 7 day therapy with follow up at day 0 and day 7	—

Secondary

Measure	Time frame
Wound healing achieved by reduction in surgical site infection Surgical scar assessment Increase in epithelization turnover Surgical scar assessment Increase in epithelization turnoverTimepoint: 7 day therapy with follow up at day 0 and day 7	—

Countries

India

Contacts

Public ContactMelvin George

SRM Medical College Hospital And Research Centre

tharungc@srmist.edu.in044-47432567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026